Our world is now facing a multitude of novel infectious diseases. Bacterial infections are
treated with antibiotics, albeit with increasing difficulty as many of the more common causes …

Since the rapid onset of the COVID‐19 or SARS‐CoV‐2 pandemic in the world in 2019,
extensive studies have been conducted to unveil the behavior and emission pattern of the …

In spite of the large-scale production and widespread distribution of vaccines and antiviral
drugs, viruses remain a prominent human disease. Recently, the discovery of antiviral …

Background Bacteriocins are proteins or peptides synthesized by bacteria that show
inhibitory or killing activities against various bacteria. Bacteriocins are mainly considered for …

In light of the growing resistance toward current antiviral drugs, efforts to discover novel and
effective antiviral therapeutic agents remain a pressing scientific effort. Antiviral peptides …

Currently, no specific licensed antiviral exists for treating the illness caused by dengue virus
(DENV). Therefore, the search for compounds of natural origin with antiviral activity is an …

The prolific spread of COVID-19 caused by a novel coronavirus (SARS-CoV-2) from its
epicenter in Wuhan, China, to every nook and cranny of the world after December 2019 …

Bacteriocins are antimicrobial peptides synthesised ribosomally by bacteria that can be
used as natural preservatives. One potential bacteriocin‐producing bacteria that has yet to …

Hepatitis E virus (HEV) is the notable causative agent of acute and chronic hepatic, renal,
pancreatic, neurological, and hematopoietic blood cell infections with high risk in …

Background Porcine β-defensin 2 (PBD-2), produced by host cells, is an antimicrobial
cysteine-rich cationic peptide with multi-functions. Previous studies have demonstrated that …